This Article Full Text (PDF) Other Versions of this Article: AAC.01398-07v1 52/7/2647    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Krause, K. M. Articles by Benton, B. M. Search for Related Content PubMed PubMed Citation Articles by Krause, K. M. Articles by Benton, B. M.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01398-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

Theravance, Inc., South San Francisco, CA 94080

^* To whom correspondence should be addressed. Email: bbenton{at}theravance.com.

	Abstract

The in vitro activity of telavancin was tested against 743 predominantly antimicrobial-resistant Gram-positive isolates. Telavancin was highly active against methicillin-resistant staphylococci (MIC₉₀, 0.5 - 1 µg/mL) streptococci (all MICs, 0.12 µg/mL) and VanB-type enterococci (all MICs, 4 µg/mL). Time-kill studies demonstrated the potent bactericidal activity of telavancin.